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ABSTRACT 
An unordinary case report of henoch-schonlein purpura (HSP) in a relationship with hepatitis C and compensated cirrhosis was identified in 14 y 
aged male patient. He was admitted in the pediatric department with stomach pain, yellow skin, rashes with tingling and erythematous injuries over 
the legs with agony and swelling since multi-day. He feels pain during walking and appears to be with swelling of lower leg muscles. His unusual 
liver function test was distinguished with elevated levels of bilirubin-3 mg/dl, basic phosphatase-314 U/l, aspartate aminotransferase-55 U/l and 
alanine aminotransferase-60 U/l. His skin biopsy shows up leukocytoclastic vasculitis and IgA depositions. Liver biopsy revealed nuclei enlargement 
with extensive cell change and scattered cell plates. His blood test was with the presence of the hepatitis C virus (HCV) antibodies. He was finally 
diagnosed as HSP associated with HCV and compensated cirrhosis. 
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HSP portrayed by generalized vasculitis [1]. HSP is characterized by 
non-thrombocytopenic palpable purpura, arthritis or arthralgias, 
gastrointestinal and renal involvement [2]. Inflammation also 
involves the blood vessels of the skin, lungs and focal sensory 
system with a mind-boggling store of immunoglobulin A (IgA) [3, 4] 
influencing transcendently in children [5]. HSP builds up the 
indications of rash, particularly finished legs, stomach pain, 
subcutaneous oedema, joint pain and glomerulonephritis [6]. HSP 
can influence any organ, physical examination observations are 
required. An exact reason for the cause of HSP is not known, but it is 
believed to be multifactorial, with hereditary, natural, and antigenic 
parts [7, 8]. It is difficult to distinguish by skin biopsy, which can 
show leukocytoclastic vasculitis and IgA depositions [9]. 
HCV is a major cause of liver disease and the potential cause of 
substantial morbidity and mortality worldwide [10]. Hepatitis C 
caused by HCV can be analyzed by the discovery of immunizing to 
HCV in the blood test by the immunoassay method [11] and 
identification of IgM antibodies against hepatitis C infection antigens 
[12]. HCV disease can do significant damage to the liver and leads to 
cirrhosis. It's not surprising that numerous individuals with 
hepatitis C don't know they have a life-threatening disease which 
can lead to liver cirrhosis. There are two phases of cirrhosis 1. 
Compensated cirrhosis means the body still functions despite 
decreased liver function and scarring. 2. Decompensated cirrhosis 
implies that body functions are separated where serious side effects 
like kidney failure, variceal haemorrhage, and hepatic 
encephalopathy may occur. Indications of cirrhosis are because of 
hepatitis C are fatigue, nausea, loss of appetite, weight reduction, 
wounding, itchy skin, jaundice, swelling in legs, ascites, hepatorenal 
disorder [13]. 
A few studies reveal hepatitis C associated IgA/IgM mixed 
cryoglobulinaemia can't be ruled out regardless of a negative 
cryoglobulin screen [14] on two occasions. In this patient, an IgA 
mediated vasculitis may have been the nidus for thrombus 
development and abdominal catastrophe. The role of liver cirrhosis 
in the advancement of HSP is fascinating. Patients may create HSP as 
because of an impact of abnormal liver metabolism of IgA circulating 
immune complexes that is an impaired clearance of IgA complex in 
liver cirrhosis resulting about tissue depositions [15, 16], despite the 
fact that this is known to occur without overt vasculitis [16]. This 
mechanism appears to be in this case. The preceding HCV might 
have contributed to the formation of the immune complex. 
There is no particular treatment for HSP. Acetaminophen or NSAIDs 
can be used for pain management and some of the time 
corticosteroids may also be used [17]. 
CASE REPORT 
A male patient, aged 14 y admitted in the pediatric department with 
chief complaints of the stomach pain, yellow skin, rashes with 
tingling and erythematous sores over the legs with pain and swelling 
since one day. He feels pain during walking and appears to be 
swelling of lower leg muscles. There is no history of rash after food 
consumption, medicine use, insect bite, and there is no cough and 
swelling of the neck to the patient. His birth and improvement 
history was observed to be normal. Physical examinations, 
biochemical reports, complete blood picture and urine examinations 
seem to be normal. Peripheral smear test and ASO tube test were 
negative. His liver function test was observed to be elevated levels of 
total bilirubin-3 mg/dl, alkaline phosphatase-314 U/l, aspartate 
aminotransferase-55 U/l and alanine aminotransferase-60 U/l. His 
skin biopsy exhibits leukocytoclastic vasculitis with IgA depositions. 
Liver biopsy reveals nuclei enlargement with large cell change and 
disorganized cell plates. His blood test was positive with the 
presence of antibodies to HCV. He was finally diagnosed as HSP to 
have hepatitis C and compensated cirrhosis.  
The patient was treated with IV ceftriaxone 1.125g+tazobactam 500 
mg, IV netilmicin 50 mg BD, IV ranitidine 50 mg BD, IV pheniramine 
1.5 cc BD, IV dexamethasone 1cc BD, tablet paracetamol 500 mg, 
tablet calcium, syrup multivitamin. He was counselled with a way of 
lifestyle changes in diet aspects.  
DISCUSSION 
An uncommon case report HSP association with hepatitis C and 
compensated liver cirrhosis were identified in a pediatric 
department. A male patient aged 14 y admitted in the pediatric 
department with stomach pain, yellow skin, rashes with rashes and 
erythematous injuries over the legs with pain and swelling since one 
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day. He feels pain during walking and appears to be swelling of 
lower leg muscles.  
An elevated level of bilirubin, alanine aminotransferase, aspartate 
aminotransferase, and alkaline phosphatase reveal liver damage to 
the patient. Patient's skin biopsy shows leukocytoclastic blood 
vessel vasculitis with IgA depositions, and liver biopsy reports with 
nuclei enlargement with a vast cell change of liver tissue which is 
considered as HSP Immunoassay method for a blood test of patient 
reports the presence of antibody to HCV indicates the condition of 
hepatitis C. 
The patient might be infected with HCV long back without creating 
any side effects. So it turned into a serious approach towards 
cirrhosis. There might be a blockage of flow in the biliary tract or 
buildup of biliary pressure in the liver. The patient's body functions 
well, although after understanding cirrhosis, so it was considered as 
compensated liver cirrhosis.  
A literature report says hepatitis C is associated with an IgA/IgM 
mixed cryoglobulinemia, but an IgA mediated vasculitis may have 
been the nidus for thrombus formation and abdominal catastrophe. 
The patient was developed HSP as due to the consequence of liver 
metabolism of IgA circulating immune complexes that is an impaired 
clearance of IgA complex in liver cirrhosis resulting in tissue 
deposition. This mechanism seems to be considered well for this 
patient. The preceding HCV might be formed in the patient due to 
the formation of immune. Nephritis is the most vital long-term 
prognostic factor in HSP; the transient prognostic factor is 
gastrointestinal illness can lead to death if there is no early 
treatment and care.  
He was treated with acetaminophen, corticosteroids, cephalosporin 
anti-infective agents and antihistamines. The way of lifestyle 
changes improves a state of the liver. 
This case is considered to a remarkable case report because HSP in 
the early adult stage is uncommon; however, HSP usually occurs in 
the children. 
CONCLUSION 
An unordinary case report HSP association with hepatitis C and 
compensated cirrhosis require a nearby observing. Early conclusion 
and early treatment of hepatitis C are more essential it might 
prompt cirrhosis. A rate of HSP with cirrhosis has been expanding 
around the world. This condition has a long-term prognostic factor 
in causing nephritis, short-term factor to cause gastrointestinal 
disease in which both can lead to death if untreated, so early 
therapeutic intervention with clinical implications are needed. 
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